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Background:While endovascular (ENDO) therapy has increasingly become the initial intervention of choice to treat lower
extremity peripheral arterial disease, reported outcomes for ENDO in patients with critical limb ischemia (CLI) and
diabetes have been reported to be inferior compared to open bypass surgery (OPEN). Objective data assessing the
hemodynamic success of ENDO compared to the established benchmark of OPEN are sparse. We therefore evaluated and
compared early hemodynamic outcomes of ENDO and OPEN in patients with diabetes with CLI at a single academic
center.
Methods: We studied 85 consecutive patients with diabetes and CLI who underwent 109 interventions, either ENDO
(n  78) or OPEN (n  31). The mean patient age was 69 years; 62% were men. All patients presented with either rest
pain and/or ulcer/gangrene. Per protocol, all were assessed using ankle brachial index (ABI) and toe pressure (TP)
determinations before and early postintervention.
Results: Both ENDO (ABI  0.36  0.24, P < .0001; TP  35.6  24.1, P < .0001) and OPEN (ABI  0.39 
0.17, P < .0001; TP  34.3  24.0, P < .0001) resulted in significant hemodynamic improvement. There was no
statistically significant initial difference between the two types of intervention (ABI, P  .6; TP, P  .6).
Conclusions:These data suggest that with appropriate patient selection, each intervention is similarly efficacious in initially
improving hemodynamics. If the intermediate or long-term results of ENDO for CLI in people with diabetes are inferior,
the problem is not one of initial hemodynamic response, but more likely due to differing patient characteristics or
durability of the intervention. (J Vasc Surg 2012;56:380-6.)
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cDue to rapid technological advancements, endovascu-
lar therapy (ENDO) has increasingly become the initial
treatment option for lower extremity peripheral arterial
disease (PAD), not only for patients with claudication, but
also for those with critical limb ischemia (CLI).1-5 Despite
this major paradigm shift in clinical practice, the outcomes
of ENDO for PAD are difficult to evaluate and compare
with established benchmarks from open bypass surgery
(OPEN). This difficulty is due to many factors, including
the lack of randomized trials, incomplete characterization
of indications for intervention, mixing of arterial segments,
extent of disease treated, the multiplicity of ENDO tech-
niques used, the exclusion of early treatment failures, cross-
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380ver to OPEN bypass during follow-up, and the paucity of
ntermediate and long-term patency/limb salvage rates in
ife-table format. These limitations are particularly prob-
ematic when one tries to assess the outcome of ENDO in
atients with diabetes and CLI.6
A recent randomized, prospective trial comparing pref-
rential use of endovascular therapy first vs open surgery in
atients with severe limb ischemia demonstrated no signif-
cant difference in amputation-free survival at 6 months or
n health-related quality of life at 1 year. However, reduced
mputation-free survival and increased all-cause mortality
ere found in the endovascular treatment group after 2
ears.7,8 These studies could support the notion that
ndovascular therapy might produce comparable early
nd intermediate but inferior long-term outcomes com-
ared to OPEN bypass when measured in terms of
uality of life, limb salvage, primary patency, functional
utcomes, or long-term primary patency rate. Several
tudies suggest that diabetes mellitus adversely influ-
nces the outcome of ENDO. Patients with diabetes
ommonly have multilevel disease, frequently with ex-
ensive tibial artery involvement. In addition, endovas-
ular therapy in patients with diabetes has been associ-
ted with decreased initial technical success rate, reduced
rimary patency, primary-assisted patency, and a signifi-
antly decreased 5-year survival and limb salvage.9-16he surgical bypass literature generally suggests that
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Volume 56, Number 2 Zhan et al 381limb salvage rates are not significantly worse in patients
with diabetes compared with those without.17,18
Limited studies on the outcomes for ENDO in patients
with CLI and diabetes mellitus have reported outcomes for
ENDO inferior to those of OPEN bypass surgery.4,8,12,19
It is unclear whether the compromised long-term outcome
of ENDO is due to lack of initial hemodynamic success
compared to OPEN or alternatively due to decreased du-
rability of the intervention. Virtually no data exist in the
literature that objectively assess the early hemodynamic
changes after ENDO compared to the established bench-
mark of OPEN using established hemodynamic measure-
ments such as ankle brachial index (ABI) and toe pressure.
Therefore, the primary purpose of this study was to evaluate
and compare initial hemodynamic outcomes of ENDO and
OPEN in a consecutive series of patients with both diabetes
and CLI treated at a single academic center.
METHODS
Patient selection and demographics. We performed
a thorough chart abstraction of patients undergoingOPEN
bypass surgery or ENDO therapy revascularization proce-
dures at University Medical Center (a tertiary academic
teaching institute) in Tucson, Arizona, from June 2006 to
June 2010. The creation and maintenance of this lower
extremity limb salvage/diabetic foot database and ongoing
outcomes monitoring project is institutional review board
approved. From review of this database, cross-checked with
review of faculty operative logs, we identified a total of 126
consecutive patients with diabetes mellitus and a diagnosis
of CLI using Society for Vascular Surgery Rutherford di-
agnostic criteria. Among those, there were 56 patients who
underwent 72 OPEN bypass surgeries and 107 patients
who underwent 197 ENDO interventions. Only 85 of
these patients were included in the present report (see
inclusion criteria below). All patients included in the study
presented with tissue loss, gangrene, or rest pain (Ruther-
ford class 4-6)20 and had both preprocedure and postpro-
cedure hemodynamic data. The remainders were excluded
due to lack of complete measurements because of the
presence of heel or toe wounds or ulcers, or because of the
presence of supra-systolic ankle or toe pressures due to
medial calcinosis. Two thirds of patients (67%) initially
underwent ENDO. Twenty-eight patients underwent a
total of 31 OPEN bypass surgeries, whereas 57 patients
underwent a total of 78 ENDO therapies. A total of 23 of
85 patients (27%) underwent multiple interventions.
Among those, 11 patients (13% of total) underwent both
ENDO and OPEN interventions. Each intervention was
considered as independent and analyzed individually for
patients who underwent multiple interventions. The ma-
jority of OPEN bypass surgeries used autogenous vein
(68%, n  21) as conduit, whereas 32% of OPEN bypass
surgeries (n  10) used polytetrafluoroethylene prosthetic
graft. In the ENDO group, 50 of 78 inventions were
percutaneous transluminal angioplasty (PTA); 24 cases of
PTA and stent placement, two cases of atherectomy and
PTA, and two cases were atherectomy alone. tPatient demographics (age and gender), pertinent risk
actors (diabetes mellitus, hypertension, dyslipidemia, cor-
nary artery disease, and tobacco use), and major comor-
idities (renal insufficiency [serum creatinine 1.5 mg/
L], congestive heart failure, myocardial infarction, and
hronic lung disease) were obtained from the medical
ecord and recorded in Excel (Microsoft, Incorporated,
edmond, Wash).
Methodology for analyzing hemodynamic out-
omes. The primary objective of this study was to
valuate the early hemodynamic response after OPEN or
NDO revascularization procedures. Doppler-derived ABI
nd toe pressures were measured in the vascular laboratory
sing standard protocols (Unetixs MultiLab series, Un-
tixs, North Kingstown, RI; Parks Flo-laboratory system,
arks Medical Electronics, Aloha, Ore). We excluded pa-
ients with supra-systolic ABI (ABI 1.3) due to medial
alcinosis from our study groups. For both study groups,
BIs and toe pressures were determined immediately be-
ore intervention and within 6 weeks of the revasculariza-
ion. Each intervention was treated as an independent
ntervention and analyzed individually. The absolute and
ercentage changes in ABI and toe pressure were recorded
n a database for further analysis. We also noted any major
mputation among study patients at any time after the
ntervention (mean follow-up was 13  12 months in the
PEN group and 15  12 months in the ENDO group).
major amputation was defined as a below or above knee
mputation of the ipsilateral lower extremity.
Statistical analysis. Statistical analyses were per-
ormed using SPSS software (SPSS, Chicago, Ill). Pearson
2 test was applied to compare patient demographics and t
est was applied to compare hemodynamic outcomes be-
ween the two study groups. P  .05 is considered statisti-
ally significant. All data are presented as mean  SD,
nless otherwise stated.
ESULTS
Patient demographics. The OPEN and ENDO
roups were of comparable median ages (OPEN: 71  10
ears; ENDO: 68  11 years) and gender distributions
OPEN: 39% women and 61% men; ENDO: 35% women
nd 65% men). All major risk factors we examined did not
iffer significantly between the two study groups (Table I).
oth groups also shared significant comorbidities (Table I).
oth groups had a comparable prevalence of congestive
eart failure and chronic lung disease. The ENDO group
ad a higher prevalence of renal failure than the OPEN
roup (ENDO: 35%; OPEN: 18%), whereas, a history of
yocardial infarction was higher in the OPEN group (29%;
NDO: 18%). However, these differences were not signif-
cant (P  .1 for renal insufficiency; P  .24 for history of
yocardial infarction; Table I).
We further characterized patients in both study groups
sing the Rutherford classification.20 In the ENDO group,
he distribution of Rutherford classes was 15% (n  12)
lass 4, 55% (n  43) class 5, and 29% (n  23) class 6. In
he OPEN group, there were 16% (n 5) class 4, 48% (n
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August 2012382 Zhan et al15) class 5, 35% (n  11) class 6. The majority (84%) of
patients in each group were in Rutherford class 5 or 6
(Table II).
The majority of study patients (85%, n 72) presented
with lesions at a single level, whereas 15% (n  13) had
lesions at multiple levels. We compared the level of inter-
vention between the two study groups. Among the 78 total
ENDO interventions, 51% (n  40) were at the femoro-
popliteal level, 40% (n 31) at the tibial level, and 9% (n
7) were aorta-iliac. In comparison, the majority of 31
OPEN interventions were at the tibial level (55%, n 40).
The remainingOPEN interventions included 35% (n 11)
at the femoral-popliteal level and 10% (n 3) for aorto-iliac
lesion (Table III).
Comparisons of immediate hemodynamic out-
comes. The mean preintervention ABI was 0.51 
0.27 (n  56) within the ENDO group. Mean ABI im-
proved to 0.86  0.26 (n  56) after ENDO; the differ-
ence between preintervention and postintervention ABI
was 0.36  0.24 (n  56, P  .0001). In comparison, the
mean ABI for patients undergoing OPENwas 0.50 0.20
(n  15). After bypass, the ABI improved to 0.90  0.18
Table I. Patient demographics
OPEN
Total number of patients 28
Total number of interventions 31
Median age  SD, years (range) 71  10 (51-
(70, n  20,
(80, n  7, 2
Gender (%)
Female 11 (39)
Male 17 (61)
Risk factors (%)
Diabetes 28 (100)
Hypertension 21 (75)
Dyslipidemia 11 (39)
CAD 10 (36)
Smoking 5 (18)
Comorbidities (%)
Renal insufficiency 5 (18)
CHF 7 (25)
MI 8 (29)
COPD 3 (11)
CAD, Coronary artery disease; CHF, congestive heart failure; COPD, chron
infarction; OPEN, Open bypass surgery.
Table II. Distribution of Rutherford class in OPEN
bypass surgery and ENDO therapy groups
Rutherford class OPEN ENDO P value
4 16% (n  5) 15% (n  12) .37
5 48% (n  25) 55% (n  43) .54
6 35% (n  11) 29% (n  23) .76
Total number of
interventions
31 78
ENDO, Endovascular therapy; OPEN, Open bypass surgery.(n 15). The mean ABI change was 0.39 0.17 (n 15, w .0001) in the OPEN study group. When the preinter-
entional, postinterventional ABI, and ABI improvements
ere compared between the ENDO and OPEN groups,
here was no statistically significant difference (P  .9, .6,
nd .6, respectively; Table IV).
We also compared differences in toe pressures in re-
ponse to either ENDO or OPEN interventions. The mean
oe pressure before intervention was 38.2 28.34 mmHg
n  57) in the ENDO group and 28.3  26.8 mm Hg
n  24) in the OPEN group. There was no statistically
ignificant difference of preintervention toe pressures be-
ween the ENDO and OPEN groups (P  .15, Table V).
n the ENDO group, the toe pressure after intervention
mproved to 71.7  35.0 mm Hg (n  57), a mean
ifference of 33.7 24.4 mmHg (n 57, P .0001). In
he OPEN group, the mean postoperative toe pressure was
2.7  27.8 mm Hg (n  24) with an improvement of
4.3 24.0 mm Hg (n 24, P .0001). When compar-
ng the improvement of toe pressure between the two study
roups, there was no significant difference (P  .91; Table
). These data suggest that ENDO therapy and OPEN
ypass surgery are similarly efficacious with respect to the
egree of initial hemodynamic improvement in patients
ENDO P value
57
78
68  11 (36-88)
(70, n  27, 47%)
(80, n  12, 21%)
.23
20 (35)
37 (65)
57 (100)
37 (65) .35
25 (44) .69
25 (44) .47
9 (16) .81
20 (35) .10
12 (21) .68
10 (18) .24
6 (16) .98
structive pulmonary disease; ENDO, endovascular therapy; MI, myocardial
able III. Level of intervention in OPEN vs ENDO
evel of
ntervention OPEN ENDO P value
orto-iliac 10% (n  3) 9% (n  7) .91
emoral-popliteal 35% (n  11) 51% (n  40) .14
ibial 55% (n  17) 40% (n  31) .15
otal number of
interventions
n  31 n  78
NDO, Endovascular therapy; OPEN, Open bypass surgery.90)
71%)
5%)
ic obith diabetes mellitus and CLI.
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Volume 56, Number 2 Zhan et al 383A total of 23 of 85 patients (27%) underwent multiple
interventions. Among those, 11 patients (13% of total)
underwent both ENDO andOPEN interventions. Eight of
those 11 crossover patients eventually received an OPEN
procedure after one or several ENDO procedures. We
analyzed the hemodynamic response in those 11 patients
who underwent both interventions. They underwent 17
independent ENDO and 11 OPEN interventions. Each
intervention was considered as independent and analyzed
separately. The preintervention toe pressure was 35  23
mm Hg (n  17) and 25  21.2 mm Hg (n  11) for
ENDO and OPEN, respectively. Toe pressure improved to
62 33 mmHg (n 17) for the ENDO and 56.3 28.0
for the OPEN cohort, respectively. Both ENDO and
OPEN interventions generated comparable changes in toe
pressure and there was no statistically significant difference
(P  .68; Table VI). These findings suggest that even
among patients who crossed over from one intervention to
another, the need for reintervention was not primarily due
to failure to obtain a significant hemodynamic response
from the index intervention.
Comparison of major amputation rates. Within the
time frame of our study, a mean follow-up interval of 13
12 months in the OPEN and 15  12 months in the
Table IV. ABI improvement: OPEN vs ENDO
ABI OPEN
Preintervention (mean  SD) 0.50  0.20 (n 
Postintervention (mean  SD) 0.90  0.18 (n 
Change (mean  SD) 0.39  0.17 (n 
P value  .0001
ABI, Ankle-brachial index; ENDO, endovascular therapy; OPEN, Open byp
Table V. Toe pressure improvement: OPEN vs ENDO
Toe pressure, mm Hg OPEN
Preintervention, mean  SD 28.3  26.8 (n 
Postintervention, mean  SD 62.7  27.7 (n 
Change, mean  SD 34.3  24.0 (n 
P value  .0001
ENDO, Endovascular therapy; OPEN, Open bypass surgery.
Table VI. Toe pressure improvement in patients who
underwent both OPEN and ENDO interventions
Toe pressure (mm Hg)
OPEN
(n  11)
ENDO
(n  17) P value
Preintervention, mean
 SD
25.3  21.2 35.0  23.2 .27
Postintervention, mean
 SD
56.3  28.0 62.0  33.0 .65
Change, mean  SD 31.0  21.8 27.0  25.9 .68
P value  .012  .012
ENDO, Endovascular therapy; OPEN, Open bypass surgery.ENDO groups, the major amputation rate for the ENDO uroup (11%, n  6 of 57 patients) was comparable to that
or the OPEN group (11%, n  3 of 28 patients), respec-
ively (Table VII).
ISCUSSION
Although ENDO has increasingly become the initial
ntervention of choice for PAD, the treatment of CLI
emains controversial. The Bypass Versus Angioplasty in
evere Ischaemia of the Leg (BASIL) trial reported that in
atients presenting with severe limb ischemia due to in-
rainguinal disease, a bypass-surgery-first and a balloon-
ngioplasty-first strategy are associated with broadly similar
utcomes in terms of overall survival and amputation-free
urvival at 2 years after randomization to angioplasty-first
r bypass-first revascularization strategies.7 Beyond 2 years,
here seemed to be a benefit for OPEN bypass surgery.8
hese studies lend credence to the notion that endovascu-
ar therapy might produce comparable intermediate but
nferior long-term outcomes compared to OPEN bypass.
his notion has also been implied in numerous studies of
atients with diabetes with CLI, a particularly challenging
roup of patients requiring revascularization. The mecha-
isms by which long-term outcomes are less favorable for
NDO treatment in patients with diabetes with CLI are
ikely multifactorial. Possible explanations include a lack of
nitial hemodynamic response to ENDO treatment com-
ared to OPEN, or intrinsic limitations of ENDO, or
ENDO P value
0.51  0.27 (n  56) .90
0.86  0.26 (n  56) .56
0.36  0.24 (n  56) .60
 .0001
rgery.
ENDO P value
38.2  28.3 (n  57) .15
71.7  35.0 (n  57) .27
35.6  24.1 (n  57) .60
 .0001
able VII. Major amputation rate: OPEN vs ENDO
OPEN ENDO P value
ajor amputation 11% (n  3) 11% (n  6) NS
ean follow-up
time, mo
13  12 15  12 .52
NDO, Endovascular therapy; NS, not significant; OPEN, Open bypass
urgery.15)
15)
15)24)
24)
24)nique pathophysiologic and anatomic characteristics of
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August 2012384 Zhan et althis patient subgroup that render ENDO treatment less
durable. Surprisingly, data in the literature comparing im-
mediate hemodynamic improvement after ENDO com-
pared to OPEN are sparse. We chose ABI and toe pressure
as our primary methods of measurement because they are
noninvasive and readily available and repeatable in the
outpatient setting. They are also well-established bench-
marks to measure outcome of surgical bypass and are
accepted in Society for Vascular Surgery Rutherford Stan-
dards for hemodynamic improvement after intervention.
Our study provides support for the concept that with
careful patient selection, both treatment modalities result
in significant ABI and toe pressure improvements. Further-
more, the early postprocedural hemodynamic response is
comparable between both interventions. Our results sug-
gest that both ENDO and OPEN procedures can produce
substantial and similar early hemodynamic improvements.
It is also possible that different measurements of perfusion
should be used so as to be more uniformly applicable to this
challenging patient subgroup. Laser Doppler21,22 transcu-
taneous oximetry,23 and more recently described indocya-
nine green angiography24 are all potentially useful tech-
niques of assessing perfusion before and after
revascularization that are worthy of consideration. Trans-
cutaneous oximetry and laser Doppler scans have been used
clinically, but the reproducibility of measurements has been
questioned and the equipment is more expensive and the
studies more tedious to perform than what is required to
perform ABI and toe pressure measurements. Indocyanine
green angiography is an emerging, potentially useful tool to
determine tissue viability. Although toe pressure and ankle
brachial pressure measurements remain the noninvasive
standards for assessing the presence of CLI and can indicate
the success of a vascular procedure,25 in 17% to 24% of
patients with diabetes, the ankle brachial pressure may be
falsely elevated or unmeasurable due to medial calcifica-
tion.26 In ischemic patients, obtaining a toe pressure may
not be feasible due to the presence of ulceration, gangrene,
or previous toe amputations.26 Fluorescent angiography is
not limited by the presence of wounds, medial calcification
associated with diabetes, or by ischemia of the toes. It can
also be used to assess specific regions of the foot, such as the
hind foot in patients with heel ulceration. Toe pressures
and ABIs are often of minimal clinical use in such patients.
The use of this method in this patient population undergo-
ing revascularization procedures is worthy of future inves-
tigation.
If the intermediate/long-term results of ENDO for
CLI in people with diabetes are truly inferior, as reported
by several clinical investigators,4,8,11-15,19 then the prob-
lem is not one of an inadequate initial hemodynamic re-
sponse, but more likely due to differing patient character-
istics or durability of the intervention. Even among patients
who initially underwent ENDO and eventually required an
OPEN procedure, the initial hemodynamic response from
ENDO and OPEN procedures were both significant and
comparable. It is conceivable and highly likely that patients
with diabetes mellitus and CLI are a very heterogeneous oroup.6 Further investigation is required to better stratify
hese patients with more objective criteria. The durability
f ENDO compared with OPEN procedures remains un-
lear in patients with diabetes and CLI, but it may well be
hat restenosis after ENDO in patients with advanced foot
esions is a major issue. If perfusion worsens due to signif-
cant restenosis before the index ulcer or minor toe ampu-
ation has healed, retreatment may be necessary. Whether
uplex scan surveillance after ENDO therapy would im-
rove outcomes is also currently uncertain.27
Limitations. This study is, of course, limited by its
etrospective and nonrandomized nature. We acknowledge
hat the large number of excluded patients imposed a
imitation on our study, but this limitation reflects the
linical realities of assessing patients with leg wounds, dress-
ngs, and the frequency of medial calcinosis in patients with
iabetes. We initially identified a total of 126 consecutive
atients; 85 of whom were included in this study (67%).
he remainders were excluded due to lack of complete
easurements because of presence of heel or toe wounds or
lcers, or because of the presence of supra-systolic ankle to
oe pressure due to medial calcinosis. These exclusions
ecreased our sample size, but the inability to obtain he-
odynamic data likely affected both cohorts equally. Thus,
e do not believe it introduced appreciable selection bias
ecause there is no association between choice of interven-
ion and inability to measure the hemodynamic result.
There is also potential selection bias. The preinterven-
ion toe pressure in the OPEN bypass surgery group was
8.3 26.8 mmHg vs 38.2 28.3 mmHg in the ENDO
roup (P  .15). When preinterventional ABIs were com-
ared, there was no significant difference (OPEN: 0.50 
.20; ENDO: 0.51  0.27; P  .9). It is unclear whether
he lower preintervention toe pressure in open bypass sur-
ery reflects a more severe degree of CLI, even though the
ifference is not statistically significant. Thus, a potential
ifference in hemodynamic outcomes between ENDO and
PEN procedures could have been underestimated due to
election bias. However, patients in both groups were all
linically categorized as Rutherford class 4 to 6 and there
as no significant difference in preintervention ABI. In
ddition, all our study patients had diabetes, which is
onsidered one of the factors that can adversely affect the
utcome. Furthermore, the vast majority of our patients
ad tissue loss or gangrene, rather than rest pain, which has
ften predominated in previous publications from oth-
rs.4,8,12,19 It is important to note, in our opinion, that
NDO not only achieved significant hemodynamic im-
rovement, but also generally matched the early hemody-
amic outcomes of OPEN treatment.
Patients presenting with diabetes and CLI have a spec-
rum of manifestations of variable severity, including neu-
opathy, foot deformity, ulceration, and ischemia. Because
f these confounding factors, a better classification schema
or patients with diabetes and neuroischemic ulcers may be
equired to ultimately determine the most appropriate re-
ascularization technique. Further studies should also focus
n longer follow-up after intervention with serial, detailed
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Volume 56, Number 2 Zhan et al 385hemodynamic assessments, and standardized outcome
measurements such as the recently published objective
performance goals.28 Better objective evidence upon which
to select the most appropriate revascularization procedure
for a given patient with CLI and diabetes will perhaps
eventually be suggested by subsequent long-term follow-
up of the patients comprising the present series, but ulti-
mately, a large-scale randomized trial that appropriately
stratifies patients by anatomic distribution and extent of
occlusive disease, degree of ischemia, tissue loss, and infec-
tion will be necessary.
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Dr Mark Conrad (Boston, Mass). I would like to commend
the authors on attempting to answer a very difficult question that
we all face, and thank you for allowingme to review themanuscript
ahead of time. The authors reviewed 85 patients with diabetes who
underwent lower extremity revascularization for critical limb isch-
emia and compared the revascularization methods, endovascular
therapy (ENDO) vs open bypass surgery (OPEN), for early hemo-
dynamic outcomes as determined by changes in ankle brachial
index (ABI) and toe pressures. They concluded that appropriate
patient selection will lead to hemodynamic improvement in pa-
tients regardless of whether they have open or endovascular ther-
apy.
I have several questions. First, one of the issues that we run
into with patients with diabetes is that many have noncompressible
vessels. How many of your patients were excluded from this study
because their ABI was unattainable due to noncompressible ves-
sels?
Second, what is the role of duplex surveillance in these pa-
tients, and would it have been a better method for identifying early
hemodynamic compromise, especially in patients in whom an ABI
could not be established?
With regard to patient selection, how do you decide who
undergoes bypass at your institution?Were the bypasses performed
on patients who failed endovascular therapy first, and were the
ENDO patients those who were poor surgical candidates with
compromised conduits?
What was your rationale, including the 10% aortoiliac lesions?
As we know, aortobifemoral bypasses and iliac stents have a differ-
ent expected long-term outcome than patients who undergo in-
frainguinal interventions. Did all of the patients show ABI im-
provements? Were there any failures of treatment?
Finally, the majority of your patients were treated for ulcers.
Was there a difference in the time to ulcer healing between the two
modalities?
I enjoyed your article.
Dr Luke X. Zhan. Thank you very much, Dr Conrad, for
your generous time in reviewing this manuscript.
You have raised some very important and interesting ques-
tions.
i
iRegarding how many patients were excluded from our studies
ue to incompressible vessels, when we compiled the database for
atients who underwent interventions, there were over 300 pa-
ients whomet the criteria for diabetes and critical limb ischemia. A
ot of them either did not have hemodynamic data due to medial
alcinosis or the presence of ulcer that precluded them from such a
easurement. At the end, we included a total of 85 patients from
he initial 300 patients.
Duplex scans had not been used in this study. ABI and toe
ressures are more established benchmarks and, in our experience,
BI and toe pressures are also more reproducible than measure-
ent from duplex scans. It is an interesting idea that perhaps we
an obtain hemodynamic data from duplex scans on patients on
hom ABI and toe pressures cannot be meaningfully measured.
The third question regarding the decision for who undergoes
NDO vs OPEN bypass and whether there is any crossover. There
re very few patients who crossed over from ENDO due to failure
f OPEN bypass. The decision for OPEN vs ENDO is largely
ased on standard criteria and individual patient characteristics. In
ur institute, typically TASC D lesions were selected for open
ypass surgery. Decision is also made based on the availability of
unoff vessels, the life expectancy of a patient, the comorbidities,
nd the clinical presentation of a patient. Certain patients were
elected to undergo ENDO because of being poor surgical candi-
ates. So, indeed, we can argue about the selection bias as to which
opulation of patients got surgery and which population got
NDO therapy, but I think there can be bias either way.
DrConrad. I wanted to knowwhy you included the aortoiliac
atients instead of just doing infrainguinal and the time to heal
lcers, whether there was a difference between the two groups.
Dr Zhan. These are very important questions. We included
hem because the patients with diabetes tend to have multiple
evels of lesions, and often we will treat the inflow first. In our
xperience, by improving the inflow, sometimes it generates
nough hemodynamic response to push the patient over the hump
nd heal the foot or leg ulcer. The time to healing is a very
mportant question for the long-term clinic response. In this study,
e focused primarily on immediate response. We are certainly
nterested in following long-term outcomes, including ulcer heal-
ng. Hopefully, we will have some data to discuss in the future.
